Dexmedetomidine Hydrochloride Injection — FDA Drug Shortage

Current — Fresenius Kabi USA, LLC

The FDA lists a drug shortage record for Dexmedetomidine Hydrochloride Injection (injection) from Fresenius Kabi USA, LLC with status Current. The shortage was first posted on Apr 10, 2020. Reported reason: Demand increase for the drug

Shortage details

Status
Current
Company
Fresenius Kabi USA, LLC
Package NDC
63323-421-02
Dosage Form
Injection
Presentation
Dexmedetomidine Hydrochloride, Injection, 100 ug/1 mL (NDC 63323-421-02)
Initial Posting
Apr 10, 2020

Reason

Demand increase for the drug

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.